Document is current
Any future updates will be listed below
-
Authors
Lederhofer, Julia https://orcid.org/0000-0001-9096-9701
Borst, Andrew J. https://orcid.org/0000-0003-4297-7824
Nguyen, Lam
Gillespie, Rebecca A. https://orcid.org/0000-0001-5741-3699
Williams, Connor J.
Walker, Emma L. https://orcid.org/0009-0007-6867-211X
Raab, Julie E.
Yap, Christina
Ellis, Daniel
Creanga, Adrian https://orcid.org/0000-0002-3087-8397
Tan, Hyon-Xhi
Do, Thi H. T.
Ravichandran, Michelle https://orcid.org/0009-0005-9600-0551
McDermott, Adrian B. https://orcid.org/0000-0003-0616-9117
Le Sage, Valerie
Andrews, Sarah F. https://orcid.org/0000-0002-2583-1949
Graham, Barney S.
Wheatley, Adam K. https://orcid.org/0000-0002-5593-9387
Reed, Douglas S. https://orcid.org/0000-0003-0076-9023
King, Neil P. https://orcid.org/0000-0002-2978-4692
Kanekiyo, Masaru https://orcid.org/0000-0001-5767-1532
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (ZIAAI005003)
Department of Health | National Health and Medical Research Council (GNT1173433, GNT2009711)
Open Philanthropy Audacious Project
- License Information
-
More Information
Article History
Received: 12 December 2024
Accepted: 17 July 2025
First Online: 1 August 2025
Competing interests
: J.L., D.E., B.S.G., N.P.K., and M.K. are named inventors of a patent application describing engineered influenza neuraminidase antigens under publication number WO/2021/178621 filed by the University of Washington and the Department of Health and Human Services, USA. The remaining authors declare no competing interests.
